Skip to main content
Signal8

Cole Jeffrey Scott

SEC insider (Form 3/4/5 filer). CIK 0001751100. Chief Operating Officer at Cadrenal Therapeutics, Inc. (CVKD). 2 reported Form 4/5 transactions since Sep 2024; latest on Oct 9, 2026. Located in PONTE VEDRA, FL.

Companies Cole Jeffrey Scott has filed insider reports for

  • Cadrenal Therapeutics, Inc. (CVKD): Officer, Chief Operating Officer
Cole Jeffrey Scott profile photo

Cole Jeffrey Scott

CIK: 0001751100

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Cadrenal Therapeutics, Inc. logo
CVKD

Cadrenal Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Cadrenal Therapeutics, Inc. logo
    CVKD

    Cadrenal Therapeutics, Inc.

    Oct 9, 2026
    Award

    Stock Option

    Direct
    150K shares-
  • Cadrenal Therapeutics, Inc. logo
    CVKD

    Cadrenal Therapeutics, Inc.

    Jan 23, 2025
    Award

    Stock Options

    Direct
    25K shares-

1-2 of 2